Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model

Scandinavian Journal of Immunology

Volumn 77, Issue 5, 2013, Pages 361-371

  Ali, R ^a   Naqvi, R A ^a   Kumar, S ^a   Bhat, A A ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; EPITOPE; GAMMA INTERFERON; GRANZYME; INTERLEUKIN 2; MICROSPHERE; PALMITOYL COENZYME A; PEPTIDE; PERFORIN; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; YERSINIA PESTIS;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDES; PLAGUE; PLAGUE VACCINE; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; YERSINIA PESTIS;

EID: 84876792470     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12042     Document Type: Article

References (42)

1. Perry RD, Fetherston JD. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997;10:35-66.
2. Titball RW, Williamson ED. Vaccination against bubonic and pneumonic plague. Vaccine 2001;19:4175-84.
3. Anderson GW Jr, Heath DG, Bolt CR, Welkos SL, Friedlander AM. Short- and long-term efficacy of single-dose subunit vaccines against Y. pestis in mice. Am J Trop Med Hyg 1998;58:793-9.
4. Williamson ED, Packer PJ, Waters EL et al. Recombinant (F1 + V) vaccine protects cynomolgus macaques against pneumonic plague. Vaccine 2011;29:4771-7.
5. Powell BS, Andrews GP, Enama JT et al. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 2005;21:1490-510.
6. Wang S, Mboudjeka I, Goguen JD, Lu S. Antigen engineering can play a critical role in the protective immunity elicited by Y. pestis DNA vaccines. Vaccine 2010;28:2011-9.
7. Ren J, Dayong D, Jinlong Z et al. Protection against anthrax and plague by a combined vaccine in mice and rabbits. Vaccine 2009;27:7436-41.
8. Parent MA, Berggren KN, Kummer LW et al. Cell-mediated protection against pulmonary Y. pestis infection. Infect Immun 2005;73:7304-10.
9. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-63.
10. Nakajima R, Brubaker RR. Association between virulence of Y. pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun 1993;61:23-31.
11. Brubaker RR. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect Immun 2003;71:3673-81.
12. Lin JS, Park S, Adamovicz JJ et al. TNF-α and IFN-γ contribute to F1/LcrV- targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 2010;29:357-62.
13. Lin JS, Kummer LW, Szaba FM, Smiley ST. IL-17 contributes to cell-mediated defense against pulmonary Y. pestis infection. J Immunol 2011;186:1675-84.
14. +) T cell response. Nat Rev Immunol 2004;4:595-602.
15. + T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Y. pestis challenge. Vaccine 2011;29:6802-9.
16. Partidos CD, Obeid OE, Steward MW. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Immunology 1992;77:262-6.
17. Partidos CD, Steward MW. The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus. J Gen Virol 1992;73:1987-94.
18. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 1988;85:5409-13.
19. Liu L, Zhou X, Liu H, Xiang L, Yuan Z. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 2005;115:223-30.
20. Uppada SB, Bhat AA, Sah A, Rao DN. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Y. pestis coupled to palmitate in mice. Vaccine 2011;29:9352-60.
21. Tripathi V, Chitralekha KT, Bakshi AR et al. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Y. pestis in microsphere delivery. Vaccine 2006;24:3279-89.
22. Gupta G, Khan AA, Rao DN. Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and V antigen of Y. pestis. Scand J Immunol 2009;71:186-98.
23. + T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Y. pestis. Int Immunopharmacol 2012;12:64-73.
24. Uppada JB, Khan AA, Bhat AA, Deshmukh R, Rao DN. Humoral immune responses and protective efficacy of sequential B- and T cell epitopes of V antigen of Y. pestis by intranasal immunization in microparticles. Med Microbiol Immunol 2009;198:247-56.
25. Ali R, Kumar S, Naqvi RA, Sheikh IA, Rao DN. Multiple antigen peptide consisting of B- and T cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice. Int Immunopharmacol 2013;15:97-105.
26. Pau C-P, Luo W, McDougal JS. Chimeric multiple antigenic peptides for simultaneous detection of specific antibodies to HIV-1 groups M, N, O, and HIV-2. J Immunol Methods 2007;318:59-64.
27. Zinkernagel RM. On natural and artificial vaccinations. Annu Rev Immunol 2003;21:515-46.
28. Ma X. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 2001;3:121-9.
29. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89.
30. Li B, Yang R. Interaction between Y. pestis and the host immune system. Infect Immun 2008;76:1804-11.
31. McCluskie MJ, Krieg AM. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. Curr Top Microbiol Immunol 2006;311:155-78.
32. Klinman DM, Xie H, Little SF, Currie D, Ivins BE. CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques. Vaccine 2004;22:2881-6.
33. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004;4:249-58.
34. Bhat AA, Seth RK, Babu J, Biswas S, Rao DN. Induction of mucosal and systemic humoral immune responses in murine system by intranasal immunization with peptide antigens of P. vivax and CpG oligodeoxynucleotide (ODN) in microparticle delivery. Int Immunopharmacol 2009;9:1197-208.
35. Do Y, Park CG, Kang YS et al. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells. Eur J Immunol 2008;38:20-9.
36. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T cell differentiation: implications for vaccine development. Nat Rev Immunol 2002;2:251-62.
37. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-50.
38. Szaba FM, Kummer LW, Wilhelm LB et al. D27-pLpxL, an avirulent strain of Y. pestis, primes T cells that protects against pneumonic plague. Infect Immun 2009;77:4295-304.
39. Parent MA, Wilhelm LB, Kummer LW, Szaba FM, Mullarky IK, Smiley ST. Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Y. pestis infection. Infect Immun 2006;74:3381-6.
40. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485-517.
41. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454-67.
42. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000;165:6107-15.